Three years after its first launch in the US, there are signs that Biogen and Eisai’s Alzheimer’s disease Leqembi therapy …
Pharma Newswire™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC
Category:
Pharmaceutics
-
-
The EMA’s human medicines committee has started a review of oral complement C5 inhibitor Tavneos, prompted by information that the …
-
Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. The search …
-
The first data has emerged on the uptake of Novo Nordisk’s new oral version of GLP-1 agonist weight-loss therapy Wegovy, …
-
Listen to the article 15 min This audio is auto-generated. Please let us know if you have feedback. This is …
-
NICE has said Biogen’s Tysabri can now be used by the NHS in England and Wales to treat highly active …
-
Pharmaceutics
Beyond Botox: AbbVie’s push for broader gains in neurotoxin R&D
by Newsroomby NewsroomListen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Botox has …
-
Months of uncertainty have come to a close. The BIOSECURE Act, now part of the National Defense Authorization Act (NDAA), …
-
Pharmaceutics
Amylyx pins its next hopes on a niche drug in the obesity space
by Newsroomby NewsroomListen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Amylyx Pharmaceuticals …
-
Less than two years after buying Chinese biotech Gracell for its cell therapy platform, AstraZeneca has reported encouraging clinical results …